Showing results (1-10 of 268) with videos related to
Sort By:
Pageof 27
Therapeutic Advances in Medical Oncology|September 30, 2011
Therapeutic options in cutaneous melanoma: latest developmentsRodabe N Amaria, Karl D Lewis, Rene GonzalezClinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2024
Project Optimus Elicits the "Holistic" Benefits of PK/PD Modeling of ImmunotherapyMathangi Gopalakrishnan, Rodabe N AmariaCore Evidence|November 3, 2010
Pegylated interferon alpha-2b as adjuvant treatment of Stage III malignant melanoma: an evidence-based reviewSonia Okuyama, Rene Gonzalez, Karl D LewisTherapeutic Advances in Medical Oncology|March 1, 2019
Combined targeted therapy and immunotherapy in melanoma: a review of the impact on the tumor microenvironment and outcomes of early clinical trialsMeredith S Pelster, Rodabe N AmariaExpert Opinion on Investigational Drugs|October 17, 2008
PI-88: a novel inhibitor of angiogenesisRagini Kudchadkar, Rene Gonzalez, Karl D LewisAmerican Journal of Clinical Dermatology|July 25, 2018
Challenges and Opportunities of Neoadjuvant Treatment in Locally Advanced MelanomaMeredith A McKean, Rodabe N AmariaExpert Opinion on Pharmacotherapy|April 12, 2014
Dabrafenib for the treatment of melanomaRodabe N Amaria, Kevin B KimCurrent Treatment Options in Oncology|February 7, 2020
Neoadjuvant Immunotherapy for Locally Advanced MelanomaMeredith S Pelster, Rodabe N AmariaCancer Treatment Reviews|September 10, 2018
Multidisciplinary treatment strategies in high-risk resectable melanoma: Role of adjuvant and neoadjuvant therapyMeredith A McKean, Rodabe N AmariaInternational Journal of Dermatology|April 2, 2009
Development of vitiligo during melanoma treatment with a novel survivin inhibitor: a case report and review of the literatureMayumi Fujita, Whitney A High, Shabnam Asgari, et al.Pageof 27